‘I aspire to be an agent of change through global public health. Working at HPP allows me to focus on non-communicable disease prevention and addressing unmet health needs, thereby improving health outcomes through the implementation of evidence-based health policy research and scalable solutions.’
Tasnime joined The Health Policy Partnership in February 2021 as a Senior Researcher. She is currently involved in the lung cancer screening programme of work.
Before joining HPP, Tasnime was working on the national NHS Digital Diabetes Prevention Programme supporting people at high risk of developing type 2 diabetes mellitus. She collaborated with healthcare professionals, patients, academic institutions and clinical commissioning groups, and worked closely with King’s College London and King’s Health Partners on randomised controlled trials conducted in London and Kuwait City.
Tasnime is an Honorary Clinical Research Fellow at Imperial College London and has published in various peer-reviewed journals. Her research interests include non-communicable diseases, health inequalities, digital health, behaviour change, humanitarian health and, more recently, COVID-19.
Tasnime holds a Medicine degree and a Master of Public Health (Global Health Stream) from Imperial College London. She is fluent in English, French and Arabic, and has conversational skills in Spanish.